Desogen Articles
Stock Commentary - New York
21 June 2004
Huge leap in net income at Duramed Pharmaceuticals
24 October 2001
Stock Commentary Europe
5 August 1999
Panic Follows UK's Oral Contraceptive Warning
30 October 1995
FDA APPROVES 26 NEWDRUGS IN 1992
25 January 1993
1992 SEES SMALLER COMPANY MERGERS
4 January 1993
JOHNSON & JOHNSON RECEIVES APPROVAL
21 December 1992
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
